Literature DB >> 34789120

L-carnitine: Searching for New Therapeutic Strategy for Sepsis Management.

Adeleh Sahebnasagh1, Razieh Avan2, Mahila Monajati3, Javad Hashemi4, Solomon Habtemariam5, Sina Negintaji6, Fatemeh Saghafi7.   

Abstract

In this review, we discussed the biological targets of carnitine, its effects on immune function, and how L-carnitine supplementation may help critically ill patients. L-carnitine is a potent antioxidant. L-carnitine depletion has been observed in prolonged intensive care unit (ICU) stays, while L-carnitine supplementation has beneficial effects in health promotion and regulation of immunity. It is essential for the uptake of fatty acids into mitochondria. By inhibiting the ubiquitin-proteasome system, down-regulating the apelin receptor in cardiac tissue, and reducing β-oxidation of fatty acid, carnitine may decrease vasopressor requirement in septic shock and improve clinical outcomes of this group of patients. We also reviewed animal and clinical studies that have been recruited for evaluating the beneficial effects of L-carnitine in the management of sepsis/ septic shock. Additional clinical data are required to evaluate the optimal daily dose and duration of L-carnitine supplementation. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  L-carnitine; antioxidant; critically ill; intensive care; sepsis; septic shock

Mesh:

Substances:

Year:  2022        PMID: 34789120     DOI: 10.2174/0929867328666211117092345

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  1 in total

1.  Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study.

Authors:  Seyed Saman Talebi; Mehran Ghasemi; Maryam Etminani-Esfahani; Younes Mohammadi; Rasool Haddadi
Journal:  Pharmacol Rep       Date:  2022-08-23       Impact factor: 3.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.